You have 9 free searches left this month | for more free features.

Myeloid

Showing 26 - 50 of 5,741

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

Not yet recruiting
  • Acute Myeloid Leukemia
  • High-Risk and Very High-Risk Myelodysplastic Syndromes
  • (no location specified)
Jul 25, 2023

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
      • (no location specified)
      Nov 1, 2023

      Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +5 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

      Not yet recruiting
      • Acute Myeloid Leukemia
        • (no location specified)
        Sep 22, 2023

        Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

        Recruiting
        • Acute Myeloid Leukemia, Adult
        • cladribine + homoharringtonine + cytarabine
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital, Zhejiang University School of Med
        Jun 13, 2023

        Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

        Recruiting
        • Refractory/Relapse Acute Myeloid Leukemia
        • Kunming, Yunnan, China
          Department of Hematology,920th Hospital of Joint Logistic Suppor
        Mar 28, 2023

        Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia Trial in United States

        Recruiting
        • Refractory Acute Myeloid Leukemia
        • +4 more
        • CD371-YSNVZ-IL18 CAR T cells
        • Basking Ridge, New Jersey
        • +6 more
        Aug 29, 2023

        Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

        Recruiting
        • Acute Myeloid Leukemia
        • Suzhou, Jiangsu, China
          Qiu Huiying
        Mar 28, 2023

        Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

        Not yet recruiting
        • Chronic Myelogenous Leukemia - Chronic Phase
        • APN and medical management
        • +3 more
        • Avignon, Provence-Alpes-Côte d'Azur, France
          Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
        Oct 13, 2023

        Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • CLL1/+CD33 CAR-T
        • Fuzhou, Fujian, China
          Fujian Provincial Children's Hospital
        Jul 10, 2023

        Venetoclax Plasma Concentration and Remission in Acute Myeloid

        Not yet recruiting
        • Adult Acute Myeloid Leukemia
        • Blood sampling for venetoclax drug dosage (venous puncture)
        • (no location specified)
        Sep 13, 2023

        Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

        Recruiting
        • Relapsed/Refractory Acute Myeloid Leukemia
        • B7-H3 target, CAR gene modified gdT cell injection
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital, Zhejiang University School of Med
        Feb 15, 2023

        AML Trial in Guanzhou (CLAG)

        Not yet recruiting
        • AML
        • CLAG
        • Guanzhou, Guangdong, China
        • +1 more
        May 16, 2023

        Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • Cytokine-Induced Memory-like Natural Killer Cells
        • +2 more
        • Boston, Massachusetts
        • +1 more
        Nov 22, 2023

        GilteRInf 2022 Study (Gilteritinib Related Infections)

        Active, not recruiting
        • Acute Myeloid Leukemia
        • Roma, RM, Italy
          Maria Ilaria Del Principe
        Mar 17, 2023

        Leukemia, Myeloid, Acute Trial in Guangzhou, Hangzhou (BG1805)

        Not yet recruiting
        • Leukemia, Myeloid, Acute
        • BG1805
        • Guangzhou, Guangdong, China
        • +2 more
        Nov 1, 2023

        Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +6 more
        • Boston, Massachusetts
        • +1 more
        Mar 31, 2023

        Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

        Recruiting
        • Acute Myeloid Leukemia
        • CLL1 and CD38 dual-target CAR-T injection
        • Kunming, Yunnan, China
          920th Hospital of Joint LogisticsSupport Force of People's Liber
        Oct 26, 2023

        Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

        Completed
        • Chronic Myeloid Leukemia
          • East Hanover, New Jersey
            Novartis
          Nov 20, 2023

          Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          Jul 21, 2023

          Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

          Recruiting
          • Allogeneic Hematopoietic Stem Cell Transplantation
          • +2 more
          • VEN+AZA+Modified BUCY
          • Suzhou, Jiangsu, China
            The First Affiliated Hospital of Soochow University
          Apr 10, 2023

          Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

          Recruiting
          • Relapsed or Refractory Acute Myeloid Leukemia
          • Taiyuan, Shanxi, China
            Tao Wang
          Feb 9, 2023

          Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

          Recruiting
          • Acute Myeloid Leukemia
          • +4 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jan 27, 2023